Towards efficiency in rare disease research: what is distinctive and important?

scientific article published on 16 June 2017

Towards efficiency in rare disease research: what is distinctive and important? is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1086102476
P356DOI10.1007/S11427-017-9099-3
P8608Fatcat IDrelease_27lpxhqbxjc5daerkdyqgfrnq4
P698PubMed publication ID28639105

P2093author name stringTieliu Shi
Jinmeng Jia
P2860cites workThe Undiagnosed Diseases Network: Accelerating Discovery about Health and DiseaseQ38373599
Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?Q38390841
Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiationQ38441936
Precision medicine for metastatic breast cancer--limitations and solutions.Q38551394
Practice-based research--"Blue Highways" on the NIH roadmapQ40249321
Industrializing rare disease therapy discovery and developmentQ48261810
An audience with...Francis Collins. Interviewed by Asher MullardQ48451329
International Classification of Childhood Cancer, third editionQ49046725
Waardenburg syndrome: a rare cause of inherited neuropathy due to SOX10 mutation.Q53267844
Preparing for Precision MedicineQ58045547
The Human Phenotype Ontology: Semantic Unification of Common and Rare DiseaseQ21819337
A new initiative on precision medicineQ29615654
Rare diseases and now rare data?Q30652877
Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR).Q30832937
NIH/NCATS/GRDR® Common Data Elements: A leading force for standardized data collectionQ30913783
The Disease Ontology: fostering interoperability between biological and clinical human disease-related dataQ30975553
Data quality in rare cancers registration: the report of the RARECARE data quality studyQ31135539
Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing dataQ31159196
Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registriesQ33568343
The quality of preventive health care delivered to adults: results from a cross-sectional study in Southern Italy.Q33611064
Towards building a disease-phenotype knowledge base: extracting disease-manifestation relationship from literature.Q33796471
The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?Q34090111
If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).Q34095613
Detecting disease rare alleles using single SNPs in families and haplotyping in unrelated subjects from the Genetic Analysis Workshop 17 data.Q34176416
Addition of multiple rare SNPs to known common variants improves the association between disease and gene in the Genetic Analysis Workshop 17 dataQ34176630
Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry SwabiaQ34588405
Funding of rare disease research in Germany: a pilot studyQ35263791
The availability and affordability of orphan drugs for rare diseases in ChinaQ36625632
Familial Mediterranean fever is no longer a rare disease in JapanQ37139961
Making Every Subject Count: A Case Study of Drug Development Path for Medication in a Pediatric Rare DiseaseQ37404468
Emergence of pediatric rare diseases: Review of present policies and opportunities for improvementQ37599975
Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal diseaseQ37736041
Orphan drugs: the regulatory environmentQ38043761
Rare-disease genetics in the era of next-generation sequencing: discovery to translationQ38133704
Rare disease policies to improve care for patients in EuropeQ38366063
P433issue7
P921main subjectrare diseaseQ929833
data sharingQ5227350
P304page(s)686-691
P577publication date2017-06-16
P1433published inScience in China. Series C: Life SciencesQ2619480
P1476titleTowards efficiency in rare disease research: what is distinctive and important?
P478volume60

Reverse relations

cites work (P2860)
Q92535669Clinical Assessments and EEG Analyses of Encephalopathies Associated With Dynamin-1 Mutation
Q64102665Compound Heterozygous Gene Mutations of a Large Deletion and a Missense Variant in a Chinese Patient With Severe Congenital Myasthenic Syndrome With Episodic Apnea
Q64086966Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study
Q92564588Molecular Genetics Analysis of 70 Chinese Families With Muscular Dystrophy Using Multiplex Ligation-Dependent Probe Amplification and Next-Generation Sequencing
Q64088327Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis
Q90050740Novel Neonatal Variants of the Carbamoyl Phosphate Synthetase 1 Deficiency: Two Case Reports and Review of Literature
Q60046838RDAD: A Machine Learning System to Support Phenotype-Based Rare Disease Diagnosis
Q91584212Sodium Taurocholate Cotransporting Polypeptide (NTCP) Deficiency Hidden Behind Citrin Deficiency in Early Infancy: A Report of Three Cases
Q90399985Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria
Q61798741Two Novel AGXT Mutations Cause the Infantile Form of Primary Hyperoxaluria Type I in a Chinese Family: Research on Missed Mutation
Q60946938Whole-Genome Sequencing Identifies a Novel Variation of Gene Coordinating With Heterozygous Germline Mutation of to Enhance Hepatoblastoma Oncogenesis
Q47102658eRAM: encyclopedia of rare disease annotations for precision medicine

Search more.